Oncotelic Therapeutics, Inc. (OTLC)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 70 Thousand | - | - | 1.74 Million | - | -100.00 |
| Cost of Revenue | - | 12.84 Thousand | 61.51 Thousand | - | 60.6 Thousand | 34.18 Thousand |
| Gross Profit | 70 Thousand | -12.84 Thousand | -61.51 Thousand | 1.74 Million | -60.6 Thousand | -34.28 Thousand |
| Operating Expenses | 6.71 Million | 5.61 Million | 9.12 Million | 9.32 Million | 4.31 Million | 3 Million |
| Selling, General and Administrative Expenses | 573.72 Thousand | 4.85 Million | 5.46 Million | 5.02 Million | 2.93 Million | 2.18 Million |
| Research and Development Expenses | 61.14 Thousand | 756.91 Thousand | 3.65 Million | 4.3 Million | 1.37 Million | 815 Thousand |
| Other Expenses | 6.08 Million | 533.48 Thousand | - | - | - | -1000.00 |
| Cost and Expenses | 6.71 Million | 5.61 Million | 9.12 Million | 9.32 Million | 4.31 Million | 3 Million |
| Operating Income | -6.64 Million | -9.72 Million | -9.12 Million | -7.58 Million | -4.31 Million | -3 Million |
| Interest Expense | 1.04 Million | 2.97 Million | 2 Million | 1.99 Million | 749.6 Thousand | - |
| Income Tax Expense | - | -13.14 Million | 876.56 Thousand | 1.52 Million | 749.6 Thousand | -265 Thousand |
| Earnings before Tax | -8.2 Million | 4.67 Million | -10.51 Million | -9.97 Million | -6.63 Million | -2.73 Million |
| Net Income | -7.9 Million | 17.81 Million | -11.39 Million | -11.5 Million | -7.38 Million | -2.73 Million |
| Earnings Per Share Basic | -0.02 | 0.05 | -0.04 | -0.13 | -0.12 | -0.07 |
| Earnings Per Share Diluted | -0.02 | 0.04 | -0.04 | -0.13 | -0.12 | -0.07 |
| Weighted Average Shares Outstanding | 396.16 Million | 384.07 Million | 303.07 Million | 88.09 Million | 59.95 Million | 37.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 396.16 Million | 457.29 Million | 303.07 Million | 88.09 Million | 59.95 Million | 37.25 Million |
| Gross Margin | 1.00 | - | - | 1.00 | - | 342.89 |
| EBIT Margin | -102.30 | - | - | -4.15 | - | 32.5 Thousand |
| Profit Margin | -112.90 | - | - | -6.61 | - | 27.37 Thousand |
| EBITDA | -7.16 Million | -5.59 Million | -9.06 Million | -7.6 Million | -4.25 Million | -678.54 Thousand |
| Earnings Before Tax Margin | -94.97 | - | - | -4.36 | - | 30.02 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 70 Thousand | 70 Thousand | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | 70 Thousand | 70 Thousand | - |
| Operating Expenses | 96.58 Thousand | 167.22 Thousand | 113.46 Thousand | 634.86 Thousand | 55.52 Thousand | 238.75 Thousand |
| Selling, General and Administrative Expenses | 96.33 Thousand | 166.74 Thousand | 102.46 Thousand | - | 34.3 Thousand | 238.75 Thousand |
| Research and Development Expenses | 252.00 | 480.00 | 10.99 Thousand | - | 21.22 Thousand | 36.99 |
| Other Expenses | 10.39 Thousand | 12.53 Thousand | - | 72.24 Thousand | - | 36.98 Thousand |
| Cost and Expenses | 96.58 Thousand | 167.22 Thousand | 113.46 Thousand | 634.86 Thousand | 55.52 Thousand | 238.75 Thousand |
| Operating Income | -96.58 Thousand | -167.22 Thousand | -113.46 Thousand | -564.87 Thousand | 14.47 Thousand | -6.32 Million |
| Interest Expense | 215.61 Thousand | 234.7 Thousand | 207.68 Thousand | 1.04 Million | 185.42 Thousand | 257.39 Thousand |
| Income Tax Expense | -68.33 Thousand | -66.49 Thousand | -55.08 Thousand | -302.97 Thousand | -74.24 Thousand | -5.91 Million |
| Earnings before Tax | -278.17 Thousand | -475.17 Thousand | -791.07 Thousand | -8.2 Million | 41.06 Thousand | -6.85 Million |
| Net Income | -209.83 Thousand | -408.67 Thousand | -735.98 Thousand | -7.9 Million | 115.3 Thousand | -6.75 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | 0.00 | -0.02 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | 0.00 | -0.02 |
| Weighted Average Shares Outstanding | 401.59 Million | 399.37 Million | 399.18 Million | 396.16 Million | 397.77 Million | 394.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 401.59 Million | 399.37 Million | 399.18 Million | 396.16 Million | 397.77 Million | 394.37 Million |
| Gross Margin | - | - | - | 1.00 | 1.00 | - |
| EBIT Margin | - | - | - | - | 0.21 | - |
| Profit Margin | - | - | - | -112.90 | 1.65 | - |
| EBITDA | -96.58 Thousand | -167.22 Thousand | -113.46 Thousand | - | 14.47 Thousand | -201.77 Thousand |
| Earnings Before Tax Margin | - | - | - | -8.07 | 0.21 | - |
CLX
603228
4082
3823
ALDX
BYAGF